Ambest Pharmaceutical (China)
Beijing
About Ambest Pharmaceutical (China)
Ambest Pharmaceutical (China) is engaged in the manufacturing of large volume injectables, and research, technology transfer and technology services of pharmaceutical products. It currently holds the drug production approvals of monoammonium glycyrrhizinate and cysteine and sodium chloride injection and floium Ginkgo extract and tertram rthypyrazine sodium chloride injection.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
Canonical: https://fsome.com/organization/ambest-pharmaceutical-china-2023196 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.